Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Protella
- Development stage
- Unknown
- Lead developer
- Emblazon Life Sciences
- Modality
- Small Molecules, Peptides
- Administration
- Oral
01
Overview
Protella is a nutritional supplement marketed by Emblazon Life Sciences, an Indian pharmaceutical company based in Pune. It is part of the company's Aura brand, which focuses on women's health and wellness. Protella is typically formulated as a protein powder enriched with essential vitamins, minerals, and often includes docosahexaenoic acid (DHA) and gamma-linolenic acid (GLA). It is primarily indicated for use during pregnancy and lactation to support maternal health and fetal development, as well as for general nutritional support in patients recovering from illness or surgery.
- Brand names
- Protella
Beyond the preview
Go deeper on Protella.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Protella.